Cargando…

Individualised therapy of angiotensin converting enzyme (ACE) inhibitors in stable coronary artery disease: overview of the primary results of the PERindopril GENEtic association (PERGENE) study

In patients with stable coronary artery disease (CAD) without overt heart failure, ACE inhibitors are among the most commonly used drugs as these agents have been proven effective in reducing the risk of cardiovascular events. Considerable individual variations in the blood pressure response to ACE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brugts, J. J., de Maat, M. P. M., Danser, A. H. J., Boersma, E., Simoons, M. L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bohn Stafleu van Loghum 2011
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3247631/ https://www.ncbi.nlm.nih.gov/pubmed/21688035 http://dx.doi.org/10.1007/s12471-011-0173-6

Ejemplares similares

Individualized Angiotensin‐Converting Enzyme (ACE)‐Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk Model
por: Oemrawsingh, Rohit M., et al.
Publicado: (2016)

The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29,463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE, EUROPA and PROGRESS Trials
por: Brugts, J. J., et al.
Publicado: (2017)

Thermo-, Radio- and Photostability of Perindopril Tert-butyloamine in The Solid State. Comparison to Other Angiotensin Converting Enzyme Inhibitors
por: Wzgarda, Anna, et al.
Publicado: (2017)

A Review of the Role of Bradykinin and Nitric Oxide in the Cardioprotective Action of Angiotensin-Converting Enzyme Inhibitors: Focus on Perindopril
por: Ancion, Arnaud, et al.
Publicado: (2019)

The angiotensin-converting enzyme (ACE) gene family of Anopheles gambiae
por: Burnham, Susan, et al.
Publicado: (2005)

Angiotensin Converting Enzyme (ACE) and ACE2 Bind Integrins and ACE2 Regulates Integrin Signalling
por: Clarke, Nicola E., et al.
Publicado: (2012)

Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome
por: Gómez, Juan, et al.
Publicado: (2020)

Characterization of Angiotensin Converting Enzyme-2 (ACE2) in Human Urine
por: Lew, Rebecca A., et al.
Publicado: (2006)

Angiotensin converting enzyme gene polymorphism and influence of ACE inhibition
por: Arman, Q.
Publicado: (2010)

Comparative study of Mg/Al- and Zn/Al-layered double hydroxide-perindopril erbumine nanocomposites for inhibition of angiotensin-converting enzyme
por: Hussein Al Ali, Samer Hasan, et al.
Publicado: (2012)

Identification and characterisation of the angiotensin converting enzyme-3 (ACE3) gene: a novel mammalian homologue of ACE
por: Rella, Monika, et al.
Publicado: (2007)

Manipulating angiotensin metabolism with angiotensin converting enzyme 2 (ACE2) in heart failure
por: Patel, Vaibhav B., et al.
Publicado: (2012)

Angiotensin Converting Enzyme 2 (ACE2) Expression in the Aged Brain and Visual System
por: Hill, James M., et al.
Publicado: (2021)

Angiotensin-converting enzyme 2 (ACE2) is upregulated in Alzheimer’s disease brain
por: Ding, Qiyue, et al.
Publicado: (2020)

Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19
por: Kuba, Keiji, et al.
Publicado: (2021)

The Insertion/Deletion Polymorphism of the Angiotensin Converting Enzyme (ACE) in Parkinson’s Disease
por: Papapetropoulos, Spiridon, et al.
Publicado: (2008)

Angiotensin-I-Converting Enzyme (ACE)-Inhibitory Peptides from Plants
por: Daskaya-Dikmen, Ceren, et al.
Publicado: (2017)

Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19
por: Ni, Wentao, et al.
Publicado: (2020)

Covid-19 and the angiotensin-converting enzyme (ACE2): Areas for research
por: Omar, Michael Brandon
Publicado: (2020)

Angiotensin Converting Enzyme (ACE): A Marker for Personalized Feedback on Dieting
por: Tejpal, Shilpa, et al.
Publicado: (2020)

Purification and characterization of angiotensin-converting enzyme (ACE) from sheep lung
por: Aydin, Fatih, et al.
Publicado: (2021)

Controlled release and angiotensin-converting enzyme inhibition properties of an antihypertensive drug based on a perindopril erbumine-layered double hydroxide nanocomposite
por: Al Ali, Samer Hasan Hussein, et al.
Publicado: (2012)

The Race for ACE: Targeting Angiotensin-Converting Enzymes (ACE) in SARS-CoV-2 Infection
por: Schieffer, Elisabeth, et al.
Publicado: (2022)

Hypertension and renin-angiotensin system blockers are not associated with expression of angiotensin-converting enzyme 2 (ACE2) in the kidney
por: Jiang, Xiao, et al.
Publicado: (2020)

Conformational Fingerprinting Using Monoclonal Antibodies (on the Example of Angiotensin I-Converting Enzyme-ACE)
por: Danilov, S. M.
Publicado: (2017)

Angiotensin-Converting Enzyme-2
por: Clarke, Nicola E., et al.
Publicado: (2013)

Angiotensin-converting enzyme 2 (ACE2): Two decades of revelations and re-evaluation
por: Turner, Anthony J., et al.
Publicado: (2022)

Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin–angiotensin–aldosterone system inhibitors involving 158 998 patients
por: van Vark, Laura C., et al.
Publicado: (2012)

Calmodulin interacts with angiotensin‐converting enzyme‐2 (ACE2) and inhibits shedding of its ectodomain
por: Lambert, Daniel W., et al.
Publicado: (2008)

Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and Disease
por: Tikellis, Chris, et al.
Publicado: (2012)

Three key proteases – angiotensin-I-converting enzyme (ACE), ACE2 and renin – within and beyond the renin-angiotensin system
por: Guang, Cuie, et al.
Publicado: (2012)

Molecular and Thermodynamic Mechanisms of the Chloride-dependent Human Angiotensin-I-converting Enzyme (ACE)
por: Yates, Christopher J., et al.
Publicado: (2014)

DNA Methylation Analysis of the Angiotensin Converting Enzyme (ACE) Gene in Major Depression
por: Zill, Peter, et al.
Publicado: (2012)

Angiotensin Converting Enzyme (ACE) Inhibitor Extends Caenorhabditis elegans Life Span
por: Kumar, Sandeep, et al.
Publicado: (2016)

Measurement of Angiotensin Converting Enzyme 2 Activity in Biological Fluid (ACE2)
por: Xiao, Fengxia, et al.
Publicado: (2017)

Angiotensin Converting Enzyme-2 (ACE-2) role in disease and future in research
por: Abdul-Hafez, Amal, et al.
Publicado: (2021)

The dynamic nature of the coronavirus receptor, angiotensin-converting enzyme 2 (ACE2) in differentiating airway epithelia
por: Manna, Vincent J., et al.
Publicado: (2022)

Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1–7) levels in experimental biliary fibrosis()
por: Herath, Chandana B., et al.
Publicado: (2007)

New Perspectives in the Renin-Angiotensin-Aldosterone System (RAAS) I: Endogenous Angiotensin Converting Enzyme (ACE) Inhibition
por: Fagyas, Miklós, et al.
Publicado: (2014)

Angiotensin converting enzyme-2 (ACE2) and its possible roles in hypertension, diabetes and cardiac function
por: Warner, Fiona J., et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_0qq2rq19r7nh98aqm6dt01endo